Subjects | 5 | 5 | 5 |
Age years | 36.4±12.72 | 42.1±16.06 | 40.9±11 |
Males:females | 3:2 | 2:3 | 0:5 |
Duration of asthma years | N/A | 21.2±15.32 | 25.56±13.24 |
Inhaled corticosteroid dose μg BDP equivalent | 0 | 480±582.71 | 1688.89±176.38 |
Atopy | 0 | 3 | 5 |
Receiving oral corticosteroids | 0 | 0 | 5 |
FEV1 L | 4.02±0.48 | 2.7±0.82 | 2.7±0.77 |
FEV1 % predicted | 104.23±7.28 | 84.48±18.34 | 81.42±14.82 |
FEV1/FVC % | 78.89±5.98 | 73.98±9.67 | 69.62±9.31 |
PC20 mg·mL−1 | >16 | 0.75±9.31 | Not performed |